FIELD: chemistry.
SUBSTANCE: invention relates to novel tricyclic derivatives of formula 1.
[Formula 1]
EFFECT: technical result is obtaining novel compounds which have inhibitory activity against PARP-1, tankirase-1 or tankyrase-2 and can be effectively used for preventing or treating mediated diseases.
10 cl, 9 tbl, 192 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL TRICYCLIC DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SAID DERIVATIVE | 2009 |
|
RU2470934C1 |
| ISOQUINOLINONE DERIVATIVES, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DISEASES ASSOCIATED WITH POLY(ADP-ribose)POLYMERASE-1, CONTAINING THEM AS ACTIVE INGREDIENT | 2020 |
|
RU2815480C1 |
| NOVEL CRYSTALLINE ACID-ADDITION SALTS OF TRICYCLIC DERIVATIVE OR THEIR HYDRATES AND METHOD FOR THEREOF OBTAINING | 2013 |
|
RU2572820C1 |
| BICYCLIC COMPOUND AND USE THEREOF | 2020 |
|
RU2831535C1 |
| NEW COMPOUND, METHOD OF ITS PREPARATION AND USE | 2021 |
|
RU2814103C1 |
| (AZA-)ISOQUINOLINE DERIVATIVES | 2013 |
|
RU2654216C2 |
| COMPOUND CONTAINING OXADIAZOLE AND A PHARMACEUTICAL COMPOSITION CONTAINING IT | 2019 |
|
RU2789456C2 |
| COMPOUND FOR DESTRUCTION OF ANDROGEN RECEPTOR AND ITS PHARMACEUTICAL USE THEREOF | 2021 |
|
RU2817356C1 |
| CONDENSED RING HETEROARYL COMPOUNDS AND USE THEREOF AS TRK INHIBITORS | 2015 |
|
RU2708674C2 |
| PYRIDAZINONE DERIVATIVES AS PARP INHIBITORS | 2008 |
|
RU2490265C2 |
